Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorSolmaz, Volkan
dc.contributor.authorAtasoy, Ozum
dc.contributor.authorErbas, Oytun
dc.date.accessioned2020-12-02T18:01:33Z
dc.date.available2020-12-02T18:01:33Z
dc.date.issued2020
dc.identifier.issn0161-6412
dc.identifier.issn1743-1328
dc.identifier.urihttps://doi.org/10.1080/01616412.2020.1747718
dc.identifier.urihttp://hdl.handle.net/11446/3652
dc.descriptionWOS: 000526603200001en_US
dc.descriptionPubMed: 32252617en_US
dc.description.abstractThis study aimed to evaluate the memory function in a rat model of fatty liver and to investigate the effects of statins on fatty liver, neuronal inflammation, oxidative stress and memory. in this study, 24 male rats were used and were divided into four groups consisting of 6 animals in each. of them, 12 rats received liquid diet containing 35% fructose for 8 weeks in order to induce hepatosteatosis, while other animals had a normal nutrition. Group 1 served as controls and had a normal nutrition with no drug treatment. the animals in Group 2 had a normal nutrition and treated with atorvastatin. Group 3 received high-fructose diet with no drug treatment and Group 4 received high-fructose diet followed by atorvastatin treatment. After the two weeks of treatment period, passive avoidance tasks evaluating the memory were performed in both the study and control groups. the liver and brain were then removed for histologic, pathologic, and biochemical evaluation. in the non-treated rats with hepatosteatosis (Group 3), the lowest mean latency time and the highest mean histopathologic liver score, and brain TNF- alpha and MDA (Measurement of lipid peroxidation) were found (p < 0.00001). on the other hand, in the animals treated with atorvastatin, all these parameters were significantly higher than that of controls and significantly lower than that of Group 3 (p < 0.05). Fatty liver can increase inflammation and cause memory disorders, and atorvastatin may have a positive effect on cognitive disorders.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Ltden_US
dc.identifier.doi10.1080/01616412.2020.1747718en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFatty liveren_US
dc.subjectmemory functionsen_US
dc.subjectinflammationen_US
dc.subjectatorvastatinen_US
dc.titleAtorvastatin has therapeutic potential for the fatty liver-induced memory dysfunction in rats, likely via its antioxidant and anti-inflammatory propertiesen_US
dc.typearticleen_US
dc.relation.journalNeurological Researchen_US
dc.departmentDBÜen_US
dc.identifier.issue6en_US
dc.identifier.volume42en_US
dc.identifier.startpage497en_US
dc.identifier.endpage503en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Solmaz, Volkan] Acibadem Bakirkoy Hosp, Neurol Dept, Istanbul, Turkey; [Atasoy, Ozum] Kartal Dr Lutfi Kirdar Egitim & Aratirma Hastanes, Radyasyon Onkol, Istanbul, Turkey; [Erbas, Oytun] Bilim Univ, Dept Physiol, Med Fac, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster